The increasing demand for specific immunological investigation and therapeutic design has spurred significant improvements in recombinant cytokine generation. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique biological roles, are frequently generated using diverse expression platforms, including bacterial hosts, animal cell populations, and vir